Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model

Figures & data

Fig. 1 Patient inclusion scheme

Table 1 Baseline demographic and laboratory characteristics of study participants in both phases

Table 2 Comparison of study outcomes in pre and post-implementation phases

Fig. 2 Comparison of subtherapeutic and supratherapeutic VCM starting doses and dosing adjustments in pre and post-implementation phases

Fig. 3 Proportion of incorrect vancomycin serum levels orders

Availability of data and materials

All data generated or analyzed during this study are included in this published article. The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.